Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium
- PMID: 31924781
- PMCID: PMC6954269
- DOI: 10.1038/s41467-019-14043-y
Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium
Abstract
Neutrophils are implicated in the pathogenesis of atherosclerosis but are seldom detected in atherosclerotic plaques. We investigated whether neutrophil-derived microvesicles may influence arterial pathophysiology. Here we report that levels of circulating neutrophil microvesicles are enhanced by exposure to a high fat diet, a known risk factor for atherosclerosis. Neutrophil microvesicles accumulate at disease-prone regions of arteries exposed to disturbed flow patterns, and promote vascular inflammation and atherosclerosis in a murine model. Using cultured endothelial cells exposed to disturbed flow, we demonstrate that neutrophil microvesicles promote inflammatory gene expression by delivering miR-155, enhancing NF-κB activation. Similarly, neutrophil microvesicles increase miR-155 and enhance NF-κB at disease-prone sites of disturbed flow in vivo. Enhancement of atherosclerotic plaque formation and increase in macrophage content by neutrophil microvesicles is dependent on miR-155. We conclude that neutrophils contribute to vascular inflammation and atherogenesis through delivery of microvesicles carrying miR-155 to disease-prone regions.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis.Atherosclerosis. 2016 Dec;255:80-89. doi: 10.1016/j.atherosclerosis.2016.11.002. Epub 2016 Nov 2. Atherosclerosis. 2016. PMID: 27835742
-
MiR-652-3p inhibition enhances endothelial repair and reduces atherosclerosis by promoting Cyclin D2 expression.EBioMedicine. 2019 Feb;40:685-694. doi: 10.1016/j.ebiom.2019.01.032. Epub 2019 Jan 20. EBioMedicine. 2019. PMID: 30674440 Free PMC article.
-
Systemic delivery of microRNA-181b inhibits nuclear factor-κB activation, vascular inflammation, and atherosclerosis in apolipoprotein E-deficient mice.Circ Res. 2014 Jan 3;114(1):32-40. doi: 10.1161/CIRCRESAHA.113.302089. Epub 2013 Oct 1. Circ Res. 2014. PMID: 24084690 Free PMC article.
-
Impact of Impaired Cholesterol Homeostasis on Neutrophils in Atherosclerosis.Arterioscler Thromb Vasc Biol. 2023 May;43(5):618-627. doi: 10.1161/ATVBAHA.123.316246. Epub 2023 Mar 23. Arterioscler Thromb Vasc Biol. 2023. PMID: 36951066 Review.
-
Neutrophil microvesicles and their role in disease.Int J Biochem Cell Biol. 2021 Dec;141:106097. doi: 10.1016/j.biocel.2021.106097. Epub 2021 Oct 13. Int J Biochem Cell Biol. 2021. PMID: 34655813 Review.
Cited by
-
A new strategy to count and sort neutrophil-derived extracellular vesicles: Validation in infectious disorders.J Extracell Vesicles. 2022 Apr;11(4):e12204. doi: 10.1002/jev2.12204. J Extracell Vesicles. 2022. PMID: 35362257 Free PMC article.
-
Beyond Macromolecules: Extracellular Vesicles as Regulators of Inflammatory Diseases.Cells. 2023 Jul 29;12(15):1963. doi: 10.3390/cells12151963. Cells. 2023. PMID: 37566042 Free PMC article. Review.
-
Significance of neutrophil microparticles in ischaemia-reperfusion: Pro-inflammatory effectors of endothelial senescence and vascular dysfunction.J Cell Mol Med. 2020 Jul;24(13):7266-7281. doi: 10.1111/jcmm.15289. Epub 2020 Jun 10. J Cell Mol Med. 2020. PMID: 32520423 Free PMC article.
-
Lipidic Nanoparticles, Extracellular Vesicles and Hybrid Platforms as Advanced Medicinal Products: Future Therapeutic Prospects for Neurodegenerative Diseases.Pharmaceutics. 2024 Mar 1;16(3):350. doi: 10.3390/pharmaceutics16030350. Pharmaceutics. 2024. PMID: 38543244 Free PMC article. Review.
-
Advances in Intercellular Communication Mediated by Exosomal ncRNAs in Cardiovascular Disease.Int J Mol Sci. 2023 Nov 11;24(22):16197. doi: 10.3390/ijms242216197. Int J Mol Sci. 2023. PMID: 38003385 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
- MR/K023977/1/MRC_/Medical Research Council/United Kingdom
- PG/13/55/30365/BHF_/British Heart Foundation/United Kingdom
- FS/14/8/30605/BHF_/British Heart Foundation/United Kingdom
- PG/14/8/30605/British Heart Foundation (BHF)/International
- FS/14/8/30605/British Heart Foundation (BHF)/International
- PG/13/55/30365/British Heart Foundation (BHF)/International
- PG/14/38/30862/BHF_/British Heart Foundation/United Kingdom
- PG/16/44/32146/BHF_/British Heart Foundation/United Kingdom
- PG/14/38/30862/British Heart Foundation (BHF)/International
- PG/09/067/27901/British Heart Foundation (BHF)/International
- PG/16/44/32146/British Heart Foundation (BHF)/International
- RG/19/10/34506/BHF_/British Heart Foundation/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
